This inventor holds 1 USPTO granted patent. Top assignee: Beecham-Wuelfing Gmbh & Co. Kg. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Dagmar Holtje: Innovator in Pharmaceutical Chemistry
Introduction
Dagmar Holtje is a notable inventor based in Gronau, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.
Latest Patents
Holtje holds a patent for "Aminoalkyl secocanthine derivatives and their use." This patent describes a compound of formula (I) or a pharmaceutically acceptable salt thereof, which includes various substituents that enhance its pharmaceutical properties. The detailed structure includes specific groups such as R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10, which play crucial roles in the compound's functionality.
Career Highlights
Dagmar Holtje is currently associated with Beecham-Wuelfing GmbH & Co. KG, where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic agents that can potentially improve patient outcomes.
Collaborations
Holtje has collaborated with esteemed colleagues such as Dietrich Thielke and Guy Nadler, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Dagmar Holtje's contributions to pharmaceutical chemistry exemplify the impact of innovative research on healthcare. Her patent and collaborative efforts highlight her role as a leading inventor in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile